ReviewCureus2026
Microbiome Differences in Preeclampsia Versus Lupus Nephritis.
Review in Cureus, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Preeclampsia (PE) and lupus nephritis (LN) share clinical features of hypertension, proteinuria, and systemic inflammation, reflecting overlapping immune dysregulation. Both conditions involve activation of pro-inflammatory cytokines and endothelial dysfunction, which contribute to organ damage. They also exhibit similarities in their microbiomes, including reduced diversity and loss of beneficial immunoregulatory taxa, which may exacerbate systemic inflammation. Despite similarities, they differ in etiology. PE results from placental dysfunction, whereas LN arises from autoimmune-driven renal injury. PE is associated with enrichment of pro-inflammatory microbes, which contribute to endothelial dysfunction and impaired trophoblast invasion. In contrast, LN exhibits gut dysbiosis involving expansion of pro-inflammatory species and depletion of protective immunoregulatory taxa, promoting intestinal permeability and renal inflammation. These shared, disease-specific microbiome features suggest potential for diagnostic differentiation and help guide future microbiome-targeted therapies.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.